Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.68 AUD | -0.32% |
|
+10.81% | +40.00% |
| 06-23 | ASX Biggest Gainers | MT |
| 06-02 | Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration; Shares Down 3% | MT |
| Market Cap | 5.32B 3.68B 3.23B 2.98B 2.79B 5.23B 347B 35.75B 13.85B 171B 13.83B 13.52B 595B | P/E 2026 * |
996x | P/E 2027 * | 111x |
|---|---|---|---|---|---|
| Enterprise Value | 5.73B 3.96B 3.48B 3.21B 3B 5.62B 374B 38.48B 14.9B 184B 14.88B 14.55B 640B | EV / Sales 2026 * |
4.22x | EV / Sales 2027 * | 3.63x |
| Free-Float |
83.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -0.32% | ||
| 1 week | +10.81% | ||
| Current month | +20.34% | ||
| 1 month | +17.72% | ||
| 3 months | +25.44% | ||
| 6 months | +31.88% | ||
| Current year | +40.00% |
| 1 week | 14.07 |  | 16.06 |
| 1 month | 12.17 | | 16.06 |
| Current year | 8.26 | | 16.06 |
| 1 year | 8.26 | | 25.87 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 2022-07-30 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2017-01-02 | |
Mark Nelson
CHM | Chairman | 66 | 2026-02-02 |
Jann Skinner
BRD | Director/Board Member | 68 | 2018-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Buy | Director | 10,200 | 0.0030% | ||
| 05-25 | Free | Director | 30,048 | 0.0089% | ||
| 05-25 | Free | Director | 23,139 | 0.0068% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | +10.81% | -35.71% | +33.11% | 3.68B | |
| +1.67% | +9.28% | -5.05% | +2.95% | 45.45B | |
| +4.84% | +9.48% | +364.58% | +617.51% | 36.09B | |
| +1.02% | +3.92% | +5.09% | +55.89% | 30.81B | |
| +1.13% | +11.37% | +17.73% | -12.61% | 30.98B | |
| +0.23% | -0.86% | +12.75% | +21.10% | 24.62B | |
| +8.79% | +12.16% | - | - | 14.78B | |
| +3.28% | +15.25% | +70.47% | +135.61% | 14.65B | |
| +1.88% | +8.59% | +13.76% | +21.62% | 13.3B | |
| +2.07% | +5.50% | +95.50% | +100.00% | 12.65B | |
| Average | +2.50% | +6.71% | +59.90% | +108.35% | 22.7B | |
| Weighted average by Cap. | +2.50% | +6.50% | +76.53% | +131.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.36B 939M 825M 760M 710M 1.33B 88.59B 9.12B 3.53B 43.67B 3.53B 3.45B 152B | 1.59B 1.1B 966M 890M 832M 1.56B 104B 10.68B 4.14B 51.15B 4.13B 4.04B 178B |
| Net income | 6.1M 4.22M 3.71M 3.41M 3.19M 5.99M 398M 40.96M 15.86M 196M 15.84M 15.49M 682M | 43.61M 30.17M 26.5M 24.42M 22.83M 42.82M 2.85B 293M 113M 1.4B 113M 111M 4.88B |
| Net Debt | 405M 280M 246M 227M 212M 398M 26.46B 2.72B 1.05B 13.04B 1.05B 1.03B 45.33B | 443M 307M 269M 248M 232M 435M 28.95B 2.98B 1.15B 14.27B 1.15B 1.13B 49.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | A$15.68 | -0.32% | 1,745,963 |
| 26-06-24 | A$15.73 | +8.04% | 3,701,343 |
| 26-06-23 | A$14.56 | +2.46% | 1,878,642 |
| 26-06-22 | A$14.21 | -2.00% | 1,273,119 |
| 26-06-19 | A$14.50 | +1.26% | 3,759,644 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
